<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 2: Fibromyalgia and Comorbid Autoimmune Conditions | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 10: Specialized Populations & Collaborative Integration</span>
 <h1 class="lesson-title">Fibromyalgia and Comorbid Autoimmune Conditions</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 2 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üíé Premium Certification Content</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential Standard</div>
 <div class="title">AccrediPro Standards Institute - Clinical Excellence Path</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#overlap-phenomenon"><span class="section-num">01</span>The Overlap Phenomenon</a></li>
 <li><a href="#symptom-mimics"><span class="section-num">02</span>Identifying Symptom Mimics</a></li>
 <li><a href="#peripheral-central"><span class="section-num">03</span>Peripheral vs. Central Pain</a></li>
 <li><a href="#energy-pacing"><span class="section-num">04</span>Adapting Energy Pacing</a></li>
 <li><a href="#root-assessment"><span class="section-num">05</span>Tailoring Root Assessments</a></li>
 <li><a href="#movement-safety"><span class="section-num">06</span>Movement Safety & Contraindications</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Module Connection:</strong> In Lesson 1, we established the <strong>Collaborative Care Model</strong>. Now, we apply that model to the specific complexity of autoimmune overlap, where the line between systemic inflammation and central sensitization becomes blurred.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Navigating the Double Burden</h3>
 <p>Welcome to one of the most clinically significant lessons in this certification. As a <strong>Certified Fibromyalgia Specialist‚Ñ¢</strong>, you will frequently encounter clients who don't just have Fibromyalgia, but are also managing Lupus, Rheumatoid Arthritis (RA), or Sjogren‚Äôs Syndrome. This "double burden" requires a sophisticated understanding of how <span class="highlight">peripheral inflammation</span> fuels <span class="highlight">central sensitization</span>. Today, we learn how to disentangle these threads to provide safe, effective guidance.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Analyze the prevalence and neurobiological mechanisms of secondary Fibromyalgia in autoimmune populations.</li>
 <li>Distinguish between autoimmune symptom mimics and primary central sensitization symptoms.</li>
 <li>Modify the <strong>Energy Pacing (E)</strong> protocol for clients experiencing active inflammatory autoimmune flares.</li>
 <li>Identify safety contraindications for <strong>Targeted Movement (T)</strong> in comorbid populations.</li>
 <li>Develop a <strong>Root Assessment (R)</strong> strategy that accounts for multiple chronic diagnoses.</li>
 </ul>
 </div>

 <h2 id="overlap-phenomenon">The Overlap Phenomenon: Secondary Fibromyalgia</h2>
 <p>In clinical practice, Fibromyalgia is often categorized as either <strong>Primary</strong> (occurring on its own) or <strong>Secondary</strong> (occurring alongside another chronic inflammatory condition). For the autoimmune client, Fibromyalgia is often the "uninvited guest" that arrives after years of systemic inflammation.</p>

 <p>Statistics show that central sensitization is significantly more common in autoimmune populations than in the general public. A 2021 meta-analysis revealed the following prevalence of comorbid Fibromyalgia:</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Autoimmune Condition</th>
 <th>Fibromyalgia Prevalence (%)</th>
 <th>Clinical Impact</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Rheumatoid Arthritis (RA)</td>
 <td>15% ‚Äì 25%</td>
 <td>Higher disease activity scores (DAS28) despite low inflammation.</td>
 </tr>
 <tr>
 <td>Systemic Lupus Erythematosus (SLE)</td>
 <td>20% ‚Äì 35%</td>
 <td>Increased fatigue and cognitive "fog" regardless of organ involvement.</td>
 </tr>
 <tr>
 <td>Sjogren‚Äôs Syndrome</td>
 <td>15% ‚Äì 31%</td>
 <td>Significant overlap in dryness and widespread neurogenic pain.</td>
 </tr>
 <tr>
 <td>Ankylosing Spondylitis</td>
 <td>10% ‚Äì 15%</td>
 <td>Difficulty distinguishing mechanical spinal pain from central pain.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "Why" for Your Client</span>
 <p>Many clients feel like "treatment failures" because their rheumatologist says their labs look "great," yet they still feel terrible. Explain that <strong>autoimmune medications</strong> treat the "fire" (inflammation), but <strong>Fibromyalgia</strong> is the "charred wiring" (the nervous system) that remains sensitive even after the fire is out.</p>
 </div>

 <h2 id="symptom-mimics">Identifying Symptom Mimics: The Great Pretenders</h2>
 <p>One of your primary roles is helping the client (and their medical team) determine which symptom belongs to which condition. This is essential because the intervention for a Lupus flare is vastly different from the intervention for a Fibromyalgia flare.</p>

 <p><strong>The Great Pretenders:</strong>
 <ul>
 <li><strong>Joint Pain:</strong> In RA, this is usually accompanied by <em>visible swelling, heat, and redness</em> (peripheral). In Fibromyalgia, the pain is <em>periarticular</em> (around the joint) but the joint itself is structurally sound.</li>
 <li><strong>Malar Rash vs. Rosacea:</strong> The Lupus "butterfly rash" is a specific autoimmune marker, whereas Fibromyalgia clients often experience "vasomotor instability" or flushing that mimics rashes.</li>
 <li><strong>Cognitive Fog:</strong> "Lupus Fog" may be related to cerebral vasculitis, while "Fibro Fog" is typically related to sleep fragmentation (Alpha-Delta anomaly) and neurotransmitter depletion.</li>
 </ul></p>

 <!-- Case Study 1 -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë§</div>
 <div>
 <p class="title">Case Study: Sarah's Hidden Layer</p>
 <p class="subtitle">48-year-old former Nurse with RA & Fibromyalgia</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <strong>Presenting Symptoms:</strong> Sarah‚Äôs RA was well-controlled by biologics (low CRP/ESR labs), but she reported 9/10 pain, suicidal ideation due to exhaustion, and inability to walk 10 minutes. Her doctor dismissed her, saying "the RA is quiet."
 <br><br>
 <strong>Intervention:</strong> As a specialist, the coach recognized Sarah was in a <strong>Central Sensitization Overdrive</strong>, not an RA flare. Using the <strong>70% Rule</strong> (Energy Pacing) and <strong>Vagus Nerve Regulation</strong>, Sarah stopped the "Boom-Bust" cycle.
 <br><br>
 <strong>Outcome:</strong> Within 12 weeks, Sarah‚Äôs pain dropped to a 4/10. She realized her "RA pain" was actually 80% Fibromyalgia-driven. She now earns $1,500/month as a peer mentor while managing her health.
 </div>
 </div>
 </div>

 <h2 id="peripheral-central">Peripheral Inflammation vs. Central Sensitization</h2>
 <p>To be an expert, you must understand the "Crosstalk." When a client has an autoimmune condition, their body produces <strong>Pro-inflammatory Cytokines</strong> (like TNF-alpha and IL-6). These molecules don't just stay in the joints; they can cross the blood-brain barrier and "prime" the <strong>Microglia</strong> (the brain's immune cells).</p>

 <p>This process, known as <strong>Neuroinflammation</strong>, lowers the pain threshold. Essentially, the autoimmune disease acts as a constant "trigger" that keeps the Central Nervous System in a state of high alert. This is why managing the autoimmune condition is a prerequisite for stabilizing Fibromyalgia.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Lab Trap</span>
 <p>Don't be fooled by "normal" labs. A client can have a normal C-Reactive Protein (CRP) but still have high levels of Substance P in their spinal fluid. We assess the <strong>person</strong>, not just the <strong>paper</strong>.</p>
 </div>

 <h2 id="energy-pacing">Adapting Energy Pacing (E) for Autoimmune Flares</h2>
 <p>In the <strong>R.E.S.T.O.R.E. Framework‚Ñ¢</strong>, Energy Pacing is our second pillar. However, pacing must be dynamic based on the type of flare the client is experiencing.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Flare Type</th>
 <th>Primary Goal</th>
 <th>Movement Guidance</th>
 <th>Pacing Strategy</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Autoimmune/Inflammatory</strong></td>
 <td>Systemic Recovery</td>
 <td>Strict Rest; Passive Stretching only.</td>
 <td>"Emergency Pacing" - Decrease activity by 50-70%.</td>
 </tr>
 <tr>
 <td><strong>Fibro/CNS Overdrive</strong></td>
 <td>Nervous System Soothing</td>
 <td>Gentle Movement; Blood flow is vital.</td>
 <td>"Standard Pacing" - Use the 70% Rule.</td>
 </tr>
 </tbody>
 </table>

 <p>If a client with Lupus tries to "push through" an inflammatory flare using Fibromyalgia movement protocols, they risk <strong>organ damage</strong> or severe systemic setbacks. You must teach them to identify the "Deep Ache" of inflammation vs. the "Electric/Burning" pain of sensitization.</p>

 <h2 id="root-assessment">Tailoring Root Assessments (R)</h2>
 <p>When conducting a <strong>Root Assessment (R)</strong> for a comorbid client, your mapping must be more granular. You are looking for "The Trigger of the Trigger."</p>
 
 <ul>
 <li><strong>Infection Mapping:</strong> Many autoimmune conditions are triggered or exacerbated by latent viral loads (EBV, CMV). Does the client have a history of "recurrent flu-like symptoms"?</li>
 <li><strong>Gut-Immune Axis:</strong> 70-80% of the immune system resides in the gut. For the RA client, "Leaky Gut" (intestinal permeability) isn't just a Fibro trigger; it's the driver of their autoimmune activity.</li>
 <li><strong>Medication Burden:</strong> Long-term use of corticosteroids (Prednisone) for autoimmune issues can deplete magnesium and Vitamin D‚Äîboth of which are critical for Fibromyalgia management.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Medication Side Effects</span>
 <p>Always ask: "Is this a symptom, or a side effect?" For example, Hydroxychloroquine (Plaquenil) can sometimes cause muscle weakness that mimics Fibromyalgia fatigue. Collaborative integration means knowing when to suggest the client speaks to their pharmacist.</p>
 </div>

 <h2 id="movement-safety">Movement Safety & Contraindications</h2>
 <p>Safety is our highest priority. In specialized populations, the "Standard" movement protocols must be refined.</p>

 <p><strong>Contraindications for Movement in Comorbid Clients:</strong>
 <ol>
 <li><strong>Active Joint Effusion:</strong> If a joint is visibly swollen and hot (RA flare), NO exercise should be performed on that joint.</li>
 <li><strong>Photosensitivity:</strong> Lupus clients often have extreme UV sensitivity. Outdoor "Targeted Movement" must be moved indoors or to low-light hours.</li>
 <li><strong>Atlantoaxial Instability:</strong> In advanced RA, the cervical spine (C1-C2) can become unstable. <em>Never</em> suggest neck rolls or intensive cervical stretching for RA clients without medical clearance.</li>
 <li><strong>Raynaud‚Äôs Phenomenon:</strong> Common in Sjogren's and Lupus. Movement in cold environments can cause painful vasospasms in extremities.</li>
 </ol></p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "Warm Water" Rule</span>
 <p>For comorbid clients, hydrotherapy (warm water exercise) is the gold standard. It offloads the joints (autoimmune protection) while providing the sensory input needed to calm the CNS (Fibro management).</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. What is the estimated prevalence of comorbid Fibromyalgia in patients with Systemic Lupus Erythematosus (SLE)?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">Between 20% and 35%. This high prevalence underscores why Lupus patients often report high pain scores even when their Lupus is clinically "quiet."</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Why is "Emergency Pacing" required during an active autoimmune inflammatory flare?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">Unlike a pure Fibromyalgia flare where gentle movement is encouraged, an autoimmune flare involves systemic tissue/organ inflammation. Pushing through can cause further immune activation and potentially permanent joint or organ damage.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which specific cervical spine condition in RA clients is a major contraindication for neck stretching?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">Atlantoaxial Instability (instability of the C1-C2 vertebrae). This requires medical clearance and extreme caution to avoid neurological injury.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How does peripheral inflammation lead to central sensitization?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">Pro-inflammatory cytokines cross the blood-brain barrier and prime the microglia (brain immune cells), leading to neuroinflammation and a lowered pain threshold (the "wind-up" phenomenon).</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for the Specialist</p>
 <ul>
 <li><strong>Secondary Fibromyalgia</strong> is the rule, not the exception, in autoimmune populations, often affecting up to 1/3 of patients.</li>
 <li>Distinguishing <strong>Inflammatory Pain</strong> (swelling, heat) from <strong>Central Pain</strong> (burning, widespread) is the hallmark of an expert coach.</li>
 <li>Energy Pacing must be <strong>stricter</strong> during autoimmune flares than during standard Fibromyalgia flares.</li>
 <li>Movement safety requires screening for <strong>joint stability</strong> and <strong>environmental triggers</strong> (like cold or UV light).</li>
 <li>Always collaborate with the client's Rheumatologist to ensure the "Fire" (inflammation) is controlled before focusing solely on the "Wiring" (CNS).</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Duffield, S. J., et al. (2018). "The prevalence of fibromyalgia in systemic lupus erythematosus: A systematic review and meta-analysis." <em>Journal of Rheumatology</em>.</li>
 <li>Wolfe, F., et al. (2021). "The prevalence and characteristics of fibromyalgia in rheumatoid arthritis: A study of 11,832 patients." <em>Arthritis Care & Research</em>.</li>
 <li>Maffei, M. E. (2020). "Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies." <em>International Journal of Molecular Sciences</em>.</li>
 <li>Sluka, K. A., & Clauw, D. J. (2016). "Neurobiology of fibromyalgia and chronic widespread pain." <em>Neuroscience</em>.</li>
 <li>Gist, A. C., et al. (2019). "The impact of comorbid fibromyalgia on disease activity and health-related quality of life in patients with inflammatory arthritis." <em>Clinical Rheumatology</em>.</li>
 <li>Fan, A., et al. (2022). "Neuroinflammation in the pathogenesis of fibromyalgia: The role of microglia." <em>Frontiers in Neuroscience</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>